Mineralys Therapeutics, Inc. Financial Overview
Mineralys Therapeutics, Inc.'s market cap is currently $2.91B. The company's EPS TTM is $-0.52; its P/E ratio is ―; Mineralys Therapeutics, Inc. is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-0.52. See an overview of income statement, balance sheet, and cash flow financials.
